using intuitive applications that combine HTA and biostatistics
Our software is based on "HEOR," which stands for Health Economics and Outcomes Research. It provides modules that allow users to compare the effects of medical technology with current standard care. This is calculated using simulation models in which patients are simulated in current care and in a situation where the new medical technology is used. By combining evidence from clinical studies, medical guidelines, financial aspects, and indicators of quality of life, a valuable overview of the added value of the technology is created.
Our software is tailor-made to perfectly fit the unique situation of each biotech or medtech company, whether it is a small or large business.
The value of a technology can depend on many factors
Value
of technology depends on the population in which it is used
(e.g. low,
intermediate and high risk)
Whether it is used in a small hospital or major academic centre might impact the value
How current diagnostic and treatment pathways are defined significantly impacts the value of technology
Amongst other aspects, costs can differ between countries and therewith the country is an important factor in the value assessment
Adjustments to the technology can influence its value. For instance, AI technology is constantly developing and therewith the value is constantly changing
The value can differ between individuals, depending on patient and disease characteristics
